Moderate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa
Clinical trial NCT02675790 · COMPLETED
Trial details
- NCT number
- NCT02675790
- Sponsor
- Vanderbilt University Medical Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2020-03-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.